In addition, systemic inflammation and increased proinflammatory cytokines (e.g., tumor necrosis factor-α, interleukin-1, and interleukin-6) can lead to impaired insulin signaling, thereby exacerbating hyperglycemia [19,20]. The gene discussed is INS; the disease is Hyperglycemia.